ISRCTN ISRCTN92062343
DOI https://doi.org/10.1186/ISRCTN92062343
Secondary identifying numbers EU-nr 2004-004280-30
Submission date
21/06/2010
Registration date
11/08/2010
Last edited
11/08/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Gabriel Sandblom
Scientific

Dept of Gastrointestinal Surgery
Karolinska University Hospital / Huddinge
141 86 Stockholm
Sweden
Stockholm
141 86
Sweden

Phone +46 (0)70 415 82 18
Email gabriel.sandblom@ki.se

Study information

Study designDouble blind randomised placebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet
Scientific titleRandomised controlled trial of betamethasone versus placebo during open hernia repair
Study acronymBetopher
Study objectivesBetamethasone reduces postoperative pain and nausea after hernia repair.
Ethics approval(s)Uppsala Review Board approved on the 19th August 2004 (ref: 2004:M-029)
Health condition(s) or problem(s) studiedPain after groin hernia repair
InterventionPatients are randomised to receive:
1. Betamethasone: 12 mg by intravenous injection at the induction of anaesthesia
2. Placebo: sodium chloride injection fluid at the induction of anaestheia
After the initial injection, anaesthesia is conducted according to the usual routines.
Intervention typeProcedure/Surgery
Primary outcome measurePost-operative pain and nausea. Every half an hour postoperatively the level of pain is assessed using a visual analogue scale (VAS). Intake of food and drink, nausea or vomiting, VAS score when mobilised, medication, time for mobilisation and discharge from the unit are also recorded.
Secondary outcome measures1. Time to discharge
2. Need of analgetics
3. Long-term postoperative pain

By discharge the patient receives a questionnaire to be recorded the first seven postoperative days. The patient is requested to record the daily use of medicines, the minimal and maximal VAS score for pain, ability to eat and drink, mobilisation, nausea, vomiting, or any other postoperative adverse events. The day after surgery the patient is contacted by phone and asked about VAS score for pain, ability to drink and eat, nausea, and mobilisation. One month after the operation the patient is contacted a second time by phone and asked about the presence of pain, any use of analgesics, problems related to the operation, and ability to perform normal working activity.
Overall study start date01/01/2006
Completion date31/12/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit70 Years
SexBoth
Target number of participants400
Key inclusion criteriaPatients aged 18 - 70 years undergoing open surgery for groin hernia
Key exclusion criteriaAllergy to:
1. Paracetamol
2. Non-steroidal anti-inflammatory drugs (NSAID)
3. Sulfonamide antibiotics
4. Salicylate
5. Betamethasone
Date of first enrolment01/01/2006
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • Sweden

Study participating centre

Dept of Gastrointestinal Surgery
Stockholm
141 86
Sweden

Sponsor information

Dalarna Research Institute (Dalarnas forskningsråd [DFR]) (Sweden)
Research council

Kommunernas Hus i Falun
Myntgatan 2
791 51 Falun
Falun
791 51
Sweden

Phone +46 (0)23 70 91 00
Email info@dfr.se
Website http://www.dfr.se/

Funders

Funder type

Research council

Dalarna Research Institute (Dalarnas forskningsråd [DFR]) (Sweden)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan